Synapse - Sigrid Carlsson

Results (221)

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: Consequences for cancer incidence, overall mortality and cancer-specific mortality

Journal Article

Zhu, X.; Van Leeuwen, P. J.; Holmberg, E.; Bul, M.; Carlsson, S.; Schroder, F. H.; Roobol, M. J.; Hugosson, J.
Journal of Medical Screening (2012)

Fulltext@MSK | Save

Validation of the Swedish M. D. Anderson dysphagia inventory (MDADI) in patients with head and neck cancer and neurologic swallowing disturbances

Journal Article

Carlsson, S.; Rydén, A.; Rudberg, I.; Bove, M.; Bergquist, H.; Finizia, C.
Dysphagia (2012)

Fulltext@MSK | Save

The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: Results from the Gothenburg Randomized Screening Trial

Journal Article

Frånlund, M.; Carlsson, S.; Stranne, J.; Aus, G.; Hugosson, J.
BJU International (2012)

Fulltext@MSK | Save

Development and validation of the Gothenburg Trismus Questionnaire (GTQ)

Journal Article

Johnson, J.; Carlsson, S.; Johansson, M.; Pauli, N.; Rydén, A.; Fagerberg-Mohlin, B.; Finizia, C.
Oral Oncology (2012)

Fulltext@MSK | Save

Quality-of-life effects of prostate-specific antigen screening

Journal Article

Heijnsdijk, E. A. M.; Wever, E. M.; Auvinen, A.; Hugosson, J.; Ciatto, S.; Nelen, V.; Kwiatkowski, M.; Villers, A.; Páez, A.; Moss, S. M.; more...
New England Journal of Medicine (2012)

Fulltext@MSK | Save

Prostate cancer screening: Facts, statistics, and interpretation in response to the US Preventive Services Task Force review

Journal Article

Carlsson, S.; Vickers, A. J.; Roobol, M.; Eastham, J.; Scardino, P.; Lilja, H.; Hugosson, J.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Outcomes after various primary treatment for non-metastasised prostate cancer. A report from the European randomized screening trial for prostate cancer (ERSPC)